Skip to main content
Top
Published in: Acta Neuropathologica 4/2009

01-10-2009 | Correspondence

Primary leptomeningeal oligodendroglioma with documented progression to anaplasia and t(1;19)(q10;p10) in a child

Authors: Sabrina Rossi, Fausto J. Rodriguez, Renan A. Mota, Angelo P. Dei Tos, Francesco Di Paola, Matteo Bendini, Silvana Agostini, Pierluigi Longatti, Robert B. Jenkins, Caterina Giannini

Published in: Acta Neuropathologica | Issue 4/2009

Login to get access

Excerpt

Oligodendrogliomas are infiltrating gliomas typically arising in the cerebral cortex and white matter. Rare examples present with diffuse leptomeningeal involvement in the absence of a clinically/radiologically detectable intraparenchymal tumor [15, 7, 8, 10, 14, 15]. Although oligodendrogliomas are rare in children, most primary leptomeningeal oligodendrogliomas have occurred in the first decade of life (Table 1). We report the case of a 3-year-old girl, who presented with progressive regression of her ability to walk and an increase of cranial circumference. MRI showed marked hydrocephalus and diffuse leptomeningeal enhancement without supratentorial intraparenchymal lesions (Fig. 1a–c). A C3–C4 mildly enhancing 5 mm nodule was present, which could not be defined with certainty as meningeal or intraparenchymal (Fig. 1c). Cerebrospinal fluid (CSF) was xanthochromic, with high protein (177 mg/dl), normal glucose (63 mg/dl) and increased white blood cells (47 cells/mm3, 50% mononuclear). Bacterial cultures were negative, but polymerase chain reaction showed CSF positivity for M. tuberculosis. A diagnosis of basal meningitis was made and the child was unsuccessfully treated with anti-tuberculosis therapy. When a meningeal biopsy demonstrated a low-grade neuroectodermal tumor consistent with low-grade oligodendroglioma, the patient was started on chemotherapy, according to the SIOP protocol for low-grade gliomas, based on vincristine and carboplatin, changed later to vincristine and cisplatin alternating with cyclophosphamide every 6 weeks due to an allergic reaction to carboplatin. Chemotherapy was suspended at 18 months, after remarkable improvement of her clinical condition. She also received radiotherapy at the level of C2–C4, because of the gradual increase of the cervical nodule (54 Gy in 30 fractions). The child remained stable for the following 3 years, when her tumor progressed to anaplastic oligodendroglioma, as confirmed by a new biopsy of a left frontal paraventricular nodule. At this time, MRIs demonstrated multiple enhancing nodules filling the ventricles, suggesting involvement of the sub-ependymal parenchyma (Fig. 1d–f). The patient received temozolomide, but her clinical condition continued to deteriorate and she expired, 7 years from the original diagnosis.
Table 1
Cases presenting with disseminated leptomeningeal oligodendrogliomatosis
Sex/age (years)
Radiological pattern
Intraparenchymal nodule/size/site
Grade
Pathological progression
Molecular findings
Follow-up
Ref.
M/42
NA
7 mm/Tuber Cinereum
II
Not proven
NA
DOD, 1 month
[2]
F/4
NA
5 mm/chiasm
II
Not proven
NA
DOD, 3 months
[2]
M/16
NA
No
II/III
Not proven
NA
DOD, 1 year
[8]
M/31
Diffuse/nodular thickening
“Small”/Tuber Cinereum
II
Not proven
NA
DOD, 5 months
[5]
F/17
Diffuse/nodular thickening
No
II
Not proven
NA
DOD, 2 years
[4]
M/21
Diffuse/nodular thickening
No
II
Not proven
NA
DOD, 4.2 years
[14]
F/6
Diffuse/nodular thickening
No
II
Not proven
NA
DOD, 5 days
[10]
M/8
Diffuse microcystic
(after 5 years) 8 mm/spinal cord
II
Not proven
NA
DOD, 5 years
[1]
M/2.5
Diffuse/nodular thickening
Spinal cord (C6-T1)
II
Grade III (5 years)
NA
AWD, 6 years
[7]
M/2
Diffuse microcystic
No
II
Not proven
NA
AWD, 2 years
[15]
M/2
Diffuse/nodular thickening
No
II
Not proven
1p loss
AWD, 1 year
[3]
F/3
Diffuse/nodular thickening
5 mm/spinal cord
II
Grade III (6 years)
1p/19q loss
DOD, 7 years
Present case
M male, F female, NA not available, DOD dead of disease, AWD alive with disease
Literature
1.
go back to reference Armao DM, Stone J, Castillo M, Mitchell KM, Bouldin TW, Suzuki K et al (2000) Diffuse leptomeningeal oligodendrogliomatosis: radiologic/pathologic correlation. Am J Neuroradiol 21:1122–1126PubMed Armao DM, Stone J, Castillo M, Mitchell KM, Bouldin TW, Suzuki K et al (2000) Diffuse leptomeningeal oligodendrogliomatosis: radiologic/pathologic correlation. Am J Neuroradiol 21:1122–1126PubMed
2.
go back to reference Beck DJK, Russell DS (1942) Oligodendrogliomatosis of the cerebrospinal fluid pathway. Brain 65:352–372CrossRef Beck DJK, Russell DS (1942) Oligodendrogliomatosis of the cerebrospinal fluid pathway. Brain 65:352–372CrossRef
3.
go back to reference Bourne TD, Mandell JW, Matsumoto JA, Jane JA, Lopes BS (2006) Primary disseminated leptomeningeal oligodendroglioma with 1p deletion. J Neurosurg 105:465–469PubMedCrossRef Bourne TD, Mandell JW, Matsumoto JA, Jane JA, Lopes BS (2006) Primary disseminated leptomeningeal oligodendroglioma with 1p deletion. J Neurosurg 105:465–469PubMedCrossRef
4.
go back to reference Chen R, Chir B, Macdonald DR, Ramsay DA (1995) Primary diffuse leptomeningeal oligodendroglioma. J Neurosurg 83:724–732PubMedCrossRef Chen R, Chir B, Macdonald DR, Ramsay DA (1995) Primary diffuse leptomeningeal oligodendroglioma. J Neurosurg 83:724–732PubMedCrossRef
5.
go back to reference Daum S, Foncin JF, Nicolaidis S, Oeconomos D (1974) Diffuse gliomatosis of the leptomeninges and tuber oligodendroglioma. Rev Neurol 130:314–320PubMed Daum S, Foncin JF, Nicolaidis S, Oeconomos D (1974) Diffuse gliomatosis of the leptomeninges and tuber oligodendroglioma. Rev Neurol 130:314–320PubMed
6.
go back to reference Doireau V, Grill J, Lellouch-Tubiana A et al (1999) Chemotherapy for unresectable and recurrent intramedullary glial tumors in children. Br J Cancer 81:835–840PubMedCrossRef Doireau V, Grill J, Lellouch-Tubiana A et al (1999) Chemotherapy for unresectable and recurrent intramedullary glial tumors in children. Br J Cancer 81:835–840PubMedCrossRef
7.
go back to reference Gilmer-Hill HS, Ellis WG, Imbesi SG, Boggan JE (2000) Spinal oligodendroglioma with gliomatosis in a child. J Neurosurg 92:109–113PubMed Gilmer-Hill HS, Ellis WG, Imbesi SG, Boggan JE (2000) Spinal oligodendroglioma with gliomatosis in a child. J Neurosurg 92:109–113PubMed
8.
go back to reference Korein J, Feigin I, Shapiro MF (1957) Oligodendrogliomatosis with intracranial hypertension. Neurology 7:589–594PubMed Korein J, Feigin I, Shapiro MF (1957) Oligodendrogliomatosis with intracranial hypertension. Neurology 7:589–594PubMed
9.
go back to reference Kreiger PA, Okada Y, Simon S, Rorke LB, Louis DN, Golden JA (2005) Losses of chromosomes 1p and 19q are rare in pediatric oligodendrogliomas. Acta Neuropathol 109:387–392PubMedCrossRef Kreiger PA, Okada Y, Simon S, Rorke LB, Louis DN, Golden JA (2005) Losses of chromosomes 1p and 19q are rare in pediatric oligodendrogliomas. Acta Neuropathol 109:387–392PubMedCrossRef
10.
go back to reference Ng HK, Poon WS (1999) Diffuse leptomeningeal gliomatosis with oligodendroglioma. Pathology 31:59–63PubMedCrossRef Ng HK, Poon WS (1999) Diffuse leptomeningeal gliomatosis with oligodendroglioma. Pathology 31:59–63PubMedCrossRef
11.
go back to reference Perilongo G, Garre ML, Giangaspero F (2003) Low-grade gliomas and leptomeningeal dissemination: a poorly understood phenomenon. Childs Nerv Syst 19:197–203PubMed Perilongo G, Garre ML, Giangaspero F (2003) Low-grade gliomas and leptomeningeal dissemination: a poorly understood phenomenon. Childs Nerv Syst 19:197–203PubMed
12.
go back to reference Pollack IF, Finkelstein SD, Burnham J et al (2003) Association between chromosome 1p and 19q loss and outcome in pediatric malignant gliomas: results from the CCG-945 cohort. Pediatr Neurosurg 39:114–121PubMedCrossRef Pollack IF, Finkelstein SD, Burnham J et al (2003) Association between chromosome 1p and 19q loss and outcome in pediatric malignant gliomas: results from the CCG-945 cohort. Pediatr Neurosurg 39:114–121PubMedCrossRef
13.
go back to reference Raghavan R, Balani J, Perry A et al (2003) Pediatric oligodendrogliomas: a study of molecular alterations on 1p and 19q using fluorescence in situ hybridization. J Neuropathol Exp Neurol 62:530–537PubMed Raghavan R, Balani J, Perry A et al (2003) Pediatric oligodendrogliomas: a study of molecular alterations on 1p and 19q using fluorescence in situ hybridization. J Neuropathol Exp Neurol 62:530–537PubMed
14.
go back to reference Rogers L, Estes M, Rosenbloom SA, Harrold L (1995) Primary leptomeningeal oligodendroglioma: case report. Neurosurgery 36:166–169PubMedCrossRef Rogers L, Estes M, Rosenbloom SA, Harrold L (1995) Primary leptomeningeal oligodendroglioma: case report. Neurosurgery 36:166–169PubMedCrossRef
15.
go back to reference Stödberg T, Deniz Y, Esteitie N et al (2002) A case of diffuse leptomeningeal oligodendrogliomatosis associated with HHV-6 variant A. Neuropediatrics 33:266–270PubMedCrossRef Stödberg T, Deniz Y, Esteitie N et al (2002) A case of diffuse leptomeningeal oligodendrogliomatosis associated with HHV-6 variant A. Neuropediatrics 33:266–270PubMedCrossRef
Metadata
Title
Primary leptomeningeal oligodendroglioma with documented progression to anaplasia and t(1;19)(q10;p10) in a child
Authors
Sabrina Rossi
Fausto J. Rodriguez
Renan A. Mota
Angelo P. Dei Tos
Francesco Di Paola
Matteo Bendini
Silvana Agostini
Pierluigi Longatti
Robert B. Jenkins
Caterina Giannini
Publication date
01-10-2009
Publisher
Springer-Verlag
Published in
Acta Neuropathologica / Issue 4/2009
Print ISSN: 0001-6322
Electronic ISSN: 1432-0533
DOI
https://doi.org/10.1007/s00401-009-0565-5

Other articles of this Issue 4/2009

Acta Neuropathologica 4/2009 Go to the issue